Sunday , May 28 2017

From the Editor

May, 2017

  • 27 May

    May 27, 2017

    dave

    For those of you who read our Clinical newsletter, the recent Disaster Averted looked at different strengths of insulin and how we have to be aware that if anything can possibly go wrong, it will. We could not have been any more timely with that example as we have just ...

    Read More »

Latest Articles

May, 2017

Test Your Knowledge

CV Risk Management in a Patient with High BP and a Significant Family History

A 52-year-old Asian-American man presents for a wellness visit. He has borderline elevated blood pressure (136/84 mm Hg), a BMI of 27 kg/m2, and a family history of diabetes and myocardial infarction. He is a nonsmoker, drinks 1-2 glasses of wine nightly, and jogs 4-5 times/wk for 40 min. Total cholesterol is 173 mg/dL (high-density lipoprotein cholesterol, 40 mg/dL; low-density lipoprotein cholesterol, 112 mg/dL). His 10-y atherosclerotic cardiovascular disease risk is 7.5%, and takes no medications. According to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines, what's the first step you should take with this patient?

Correct

Answer: D. None of the above

Explanation:  According to the 2013 American College of Cardiology/American Heart Association cholesterol guidelines, the next best step is to initiate a clinician-patient risk discussion to weigh the risk reduction benefits against the potential adverse effects that may occur when starting preventive statin therapy or ordering additional testing. The guidelines emphasize the importance of patient preferences and shared decision-making between the clinician and the patient. For a patient with an atherosclerotic cardiovascular disease risk ?7.5%, the recommendation is to initiate a moderate- to high-intensity statin after a risk discussion.

Stone NJ, et al. J Am Coll Cardiol. 2014;63(25):2889-2934.  55 yo M w/ Elevated BP: Is Coronary Artery Calcium Scoring Appropriate?   http://quantiamd.com/player/yjmbnywfg?cid=10000076   Stone NJ, et al. J Am Coll Cardiol. 2014;63(25):2889-2934.

Incorrect

More Articles

May, 2017

  • 27 May

    More Complications from Diabetes

    Brain Pain

    Cognitive decline can accelerate, making patients especially vulnerable to mental impairment and dementia as they age.

    Read More »
  • 27 May

    Using The One-Hour Postload Glucose Can Predict Future Diabetes

    Blood in test tubes and results close up

    12-year community-based cohort study investigated whether 1-h glucose concentration could be better indicator of diagnosis.

    Read More »
  • 27 May

    Prediabetes Diagnosis Test

    iStock_000050182656_Small

    Which test do you use to determine if a patient has prediabetes? 1) fasting blood sugar 2) A1c 3) OGTT 4) Random blood sugar Follow the link to see how you and your colleagues compare!

    Read More »
  • 27 May

    Dr. Scott Isaacs Part 1, Treating T1 Vs T2

    Dr.ScottIsaacs

    Dr. Scott Isaacs talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about the differences in treating obesity in type 1 patients vs. type 2, and suggestions for medical professionals helping to treat a patient who needs to lose weight. Dr. Scott Isaacs, ...

    Read More »
  • 27 May

    Dr. Scott Isaacs Part 2, Pharmaceuticals for Diabetes and Weight Loss

    Dr.ScottIsaacs

    Dr. Scott Isaacs talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas to share how he chooses the best medication for a patient and his recommendation for how to successfully lose weight and maintain the loss. Dr. Scott Isaacs, MD, FACP, FACE is ...

    Read More »
  • 27 May

    Dr. Scott Isaacs Part 3, Nutrition and Physical Activity

    Dr.ScottIsaacs

    In a talk with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas, Dr. Scott Isaacs explains the importance of nutrition along with exercise in the treatment of obesity and the maintenance of weight loss. Dr. Scott Isaacs, MD, FACP, FACE is an endocrinologist and ...

    Read More »
  • 27 May

    Dr. Scott Isaacs Full Interview

    Dr.ScottIsaacs

    Dr. Scott Isaacs talks with Diabetes in Control Publisher Steve Freed during the AACE 2017 convention in Austin, Texas about endocrinology, obesity, and medical weight loss. Dr. Scott Isaacs, MD, FACP, FACE is an endocrinologist and adjunct instructor of Medicine at Emory University School of Medicine, Division of Endocrinology, Metabolism ...

    Read More »
  • 23 May

    Concentrated Insulin Pens and the Visually Impaired

    iStock_000003296546_Small

    An endocrinologist prescribed a U-200 TRESIBA (insulin degludec) pen for an 88-year-old woman with labile type 1 diabetes and recurrent hypoglycemia. The patient also has severe macular degeneration with visual impairment. Visually impaired patients commonly use touch and sound to assist them.An endocrinologist prescribed a U-200 TRESIBA (insulin degludec) pen for an 88-year-old woman with labile type 1 diabetes and recurrent hypoglycemia. The patient also has severe macular degeneration with visual impairment. Visually impaired patients commonly use touch and sound to assist them.

    Read More »
  • 23 May

    Michael Hill Part 9, Feedback and Cost

    michael-hill

    Michael Hill talks with Diabetes in Control Publisher Steve Freed during a Skype interview. In part 9, the conclusion of this Exclusive Interview, the response of trial participants who used the closed-loop system and managing the costs.

    Read More »
  • 23 May

    Insulin & Vascular Function Part 5

    iStock_000003049781_Small

    n this week's Homerun Slides, finding the common ground between - and possible path to treatment of - hyperglycemia and the causes of vascular disease.

    Read More »
  • 23 May

    International Textbook of Diabetes Mellitus, 4th Ed., Excerpt #75: Insulin actions in vivo: glucose metabolism Part 1 of 9

    DeFronzoCover

    Glucose is widespread in living organisms and, with protein and fat, completes the triad of the major metabolic fuels. To a much lesser extent than in plants, glucose also constitutes a building block for structural and enzymatic components of cells as well as the extracellular matrix. As a metabolic substrate, glucose is present in organisms essentially in its simple, monomeric form (alpha-D-glucopyranose) and as a branched polymer of alpha-glucose, namely glycogen. Disaccharides of glucose (lactose, maltose, and sucrose) are quantitatively less important. Glucose is present in plasma water at a concentration that — in a healthy adult who has fasted overnight — ranges between 3.6 and 5.5 mmol L−1 (65 – 99 mg dL−1 ).

    Read More »
  • 20 May

    Dr. Andrew J.M. Boulton

    Andrew-JM-Boulton

    Dr. Andrew J.M. Boulton, MD, DSc, FRCP, Professor of Medicine, University of Manchester speaks with Diabetes in Control publisher Steve Freed about the global epidemic of diabetes.

    Read More »
  • 20 May

    FDA: Black Box Warning: Amputation Risk for Canagliflozin

    iStock_000018184525_Small

    Post-marketing trial data show doubled rates compared to placebo.

    Read More »
  • 20 May

    Breastfeeding Helps to Prevent Type 1 Diabetes

    Mother With Baby Eating Healthy Meal In Kitchen

    Youths who received any breastfeeding for at least 12 months or full breastfeeding for at least six months had lower odds of developing type 1 diabetes.

    Read More »
  • 20 May

    GLP-1 Receptor Agonist for Type 1’s

    iStock_000054902090_Small

    Besides lowering A1c, study finds success with using less insulin and weight reduction.

    Read More »